Sera Prognostics (SERA) EBITDA Margin Growth (3y) (2023 - 2026)
Sera Prognostics (SERA) EBITDA Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 129.08 Bn | 126.21 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 108.57 Bn | 99.35 Bn | 6.41 Bn | 78.00 |
| 4 | Boston Scientific | 68.52 Bn | 67.07 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn | -283.00 |
| 6 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | 1,505.00 |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.88 Bn | 1.98 Bn | -184.00 |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.37 Bn | 21.25 Bn | 2.07 Bn | -763.00 |
| 10 | Sera Prognostics | 102.53 Mn | 102.53 Mn | -28,000.00 | -5.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.55 Mn |
| Dec 31, 2025 | -7.35 Mn |
| Sep 30, 2025 | -4.33 Mn |
| Jun 30, 2025 | -3.98 Mn |
| Mar 31, 2025 | 802,632.00 |
| Dec 31, 2024 | 899,519.00 |
| Sep 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | -164,917.00 |
| Dec 31, 2023 | 5.77 Mn |
| Sep 30, 2023 | 7.34 Mn |
| Jun 30, 2023 | 6.20 Mn |